Nanite
Nanite Bio is pioneering the future of genetic drug delivery with safe, resorbable polymer nanoparticles (PNPs). They combine AI-driven polymer design with multiplexed in vivo screening to develop tissue-specific delivery vectors, aiming to revolutionize gene therapy. Their mission is to solve the biggest hurdle in gene therapy—delivery—by harnessing AI and advanced materials science to create targeted, scalable, and safe gene delivery systems.
Industries
Nr. of Employees
small (1-50)
Products
Closed-loop AI-driven polymer nanoparticle design platform
An integrated platform that combines computational design, automated synthesis, first-principles characterization, high-content in vitro screening, multiplexed in vivo assays, and data pipelines to design and optimize polymer nanoparticles for targeted gene delivery.
Closed-loop AI-driven polymer nanoparticle design platform
An integrated platform that combines computational design, automated synthesis, first-principles characterization, high-content in vitro screening, multiplexed in vivo assays, and data pipelines to design and optimize polymer nanoparticles for targeted gene delivery.
Services
End-to-end development services including computational design, rapid synthesis, in vitro and in vivo screening, and characterization to produce tissue-specific polymer nanoparticle delivery candidates.
Partnership projects with external organizations and funders to apply AI-driven polymer design toward application-specific programs (examples include lung-targeting programs and HIV gene-therapy development partnerships).
End-to-end development services including computational design, rapid synthesis, in vitro and in vivo screening, and characterization to produce tissue-specific polymer nanoparticle delivery candidates.
Partnership projects with external organizations and funders to apply AI-driven polymer design toward application-specific programs (examples include lung-targeting programs and HIV gene-therapy development partnerships).
Expertise Areas
- Non-viral gene delivery
- Polymer nanoparticle engineering
- Machine learning-driven materials design
- High-throughput synthesis and screening
Key Technologies
- Machine learning for polymer design
- Closed-loop design–synthesis–test platforms
- High-throughput polymer synthesis automation
- High-content in vitro imaging and automated analysis
News & Updates
How can we unlock the full potential of biologics? Rethinking delivery could be the key...
Nanite has published a novel study using their SAYER platform for the predictive design of multimonomeric polyelectrolytes, enabling lung-specific gene delivery.
Nanite and SalioGen Therapeutics announced a research collaboration utilizing Nanite’s SAYER platform to develop a lung-targeting polymer nanoparticle for cystic fibrosis gene therapy.
Nanite will employ the SAYER platform to design and optimize polymeric delivery vehicles to deliver DNA-encoded therapeutics for HIV.
The convergence of polymer chemistry, materials science, biology, and computation lets scientists assess a plethora of polymer delivery options.
Nanite's ranking includes virus-free gene therapies and AI-hallucinated proteins among the top stories.
How can we unlock the full potential of biologics? Rethinking delivery could be the key...
Nanite has published a novel study using their SAYER platform for the predictive design of multimonomeric polyelectrolytes, enabling lung-specific gene delivery.
Nanite and SalioGen Therapeutics announced a research collaboration utilizing Nanite’s SAYER platform to develop a lung-targeting polymer nanoparticle for cystic fibrosis gene therapy.
Nanite will employ the SAYER platform to design and optimize polymeric delivery vehicles to deliver DNA-encoded therapeutics for HIV.
The convergence of polymer chemistry, materials science, biology, and computation lets scientists assess a plethora of polymer delivery options.
Nanite's ranking includes virus-free gene therapies and AI-hallucinated proteins among the top stories.